S&P Midcap 400 Portfolio (^MID, MDY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : S&P Midcap 400 Portfolio (^MID, MDY)

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Londo who started this subject	1/22/2001 4:52:08 PM
From: Londo	Read Replies (1) of 181

Kemet Corp (KEM): GREENVILLE, S.C., Jan. 22 /PRNewswire/ -- KEMET Corporation (NYSE: KEM - news) today reported record sales and earnings for the fiscal third quarter ended December 31, 2000. Net sales for the quarter increased 74% to $374.9 million, compared with $215.1 million for the same quarter last year. Net earnings were $97.4 million, or $1.10 per diluted share, compared with $18.2 million, or $0.22 per diluted share, for the same period last year. ------------------------------------------------------- The Midcap portfolio will allocate 5% of its cash towards buying 26 shares of KEM at 19 3/16. I'm expecting this stock to get slightly hammered on earnings in the short-term, but should stabalize around this area. Since P/E is going to be at the most 8 or 9, this will provide a probable yield greater than the 15% required to outperform the MDY. Limit order, buy 26 KEM @ 19 3/16. Order expires January 27th if not filled.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext